Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mastrantonio

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in miceC M Ausiello, R Lande, P Stefanelli, et al.
Cancer|March 15, 1996
A risk model for ovarian carcinoma patients using CA 125: time to normalization renders second-look laparotomy redundantG Frasci, S Conforti, F Zullo, et al.
Developments in Biological Standardization|January 1, 1997
Bordetella parapertussis infectionsP Mastrantonio, M Giuliano, P Stefanelli, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 25, 2009
Characterisation of Neisseria meningitidis C strains causing two clusters in the north of Italy in 2007 and 2008C Fazio, A Neri, S Tonino, et al.
Journal of Clinical Microbiology|December 2, 2000
Characterization of non-type B Haemophilus influenzae strains isolated from patients with invasive disease. The HI Study GroupM Cerquetti, M L Ciofi degli Atti, G Renna, et al.
Journal of Clinical Microbiology|May 23, 1998
Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolatesP Mastrantonio, P Stefanelli, M Giuliano, et al.
Infection and Immunity|July 23, 1999
Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccinesC M Ausiello, R Lande, F Urbani, et al.
International Journal of Oncology|May 14, 2011
Recovery of sensitivity to cisplatinum and epidoxorubicin by ionidamine and interferon in advanced ovarian-cancerR Iaffaioli, A Tortoriello, G Facchini, et al.
The Journal of Infectious Diseases|June 6, 2000
Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccineC M Ausiello, R Lande, F Urbani, et al.
Pediatrics|November 6, 2001
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experienceS Salmaso, P Mastrantonio, A E Tozzi, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in miceC M Ausiello, R Lande, P Stefanelli, et al.
Cancer|March 15, 1996
A risk model for ovarian carcinoma patients using CA 125: time to normalization renders second-look laparotomy redundantG Frasci, S Conforti, F Zullo, et al.
Developments in Biological Standardization|January 1, 1997
Bordetella parapertussis infectionsP Mastrantonio, M Giuliano, P Stefanelli, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 25, 2009
Characterisation of Neisseria meningitidis C strains causing two clusters in the north of Italy in 2007 and 2008C Fazio, A Neri, S Tonino, et al.
Journal of Clinical Microbiology|December 2, 2000
Characterization of non-type B Haemophilus influenzae strains isolated from patients with invasive disease. The HI Study GroupM Cerquetti, M L Ciofi degli Atti, G Renna, et al.
Journal of Clinical Microbiology|May 23, 1998
Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolatesP Mastrantonio, P Stefanelli, M Giuliano, et al.
Infection and Immunity|July 23, 1999
Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccinesC M Ausiello, R Lande, F Urbani, et al.
International Journal of Oncology|May 14, 2011
Recovery of sensitivity to cisplatinum and epidoxorubicin by ionidamine and interferon in advanced ovarian-cancerR Iaffaioli, A Tortoriello, G Facchini, et al.
The Journal of Infectious Diseases|June 6, 2000
Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccineC M Ausiello, R Lande, F Urbani, et al.
Pediatrics|November 6, 2001
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experienceS Salmaso, P Mastrantonio, A E Tozzi, et al.
Pageof 10